Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuai S Yuan

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Biopharmaceutical Statistics|August 30, 2017
Statistical inference following sample size adjustment based on the 50%-conditional-power principleY H Joshua Chen, Shuai S Yuan, Xiaoming Li
Journal of Biopharmaceutical Statistics|March 23, 2023
Application of estimand framework in ICH E9 (R1) to safety evaluationXuelong Wang, Ping Yang, Shuai S Yuan, et al.
Pharmaceutical Medicine|July 3, 2022
Global Landscape of Benefit-Risk Considerations for Medicinal Products: Current State and Future DirectionsMax Waschbusch, Lisa Rodriguez, Andreas Brueckner, et al.
JAMA|November 29, 2016
Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in WomenOle-Erik Iversen, Maria Jose Miranda, Angels Ulied, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Biopharmaceutical Statistics|August 30, 2017
Statistical inference following sample size adjustment based on the 50%-conditional-power principleY H Joshua Chen, Shuai S Yuan, Xiaoming Li
Journal of Biopharmaceutical Statistics|March 23, 2023
Application of estimand framework in ICH E9 (R1) to safety evaluationXuelong Wang, Ping Yang, Shuai S Yuan, et al.
Pharmaceutical Medicine|July 3, 2022
Global Landscape of Benefit-Risk Considerations for Medicinal Products: Current State and Future DirectionsMax Waschbusch, Lisa Rodriguez, Andreas Brueckner, et al.
JAMA|November 29, 2016
Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in WomenOle-Erik Iversen, Maria Jose Miranda, Angels Ulied, et al.
Pageof 1